The growth in the U.S. Non-Invasive Prenatal Testing (NIPT) market is largely attributed to factors such as the high risk of chromosomal abnormalities with increasing maternal age, increase in incidences of chromosomal aneuploidies among fetus, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing, rising focus on reimbursement for NIPT, increasing preference for non-invasive techniques over invasive methods and ACOG guidelines recommend NIPT for all pregnancies regardless of risk.
Key Findings:
- The United States Rises to Become Largest NIPT Test Market
- The U.S. NIPT Test Market is Expected to Register a CAGR of More Than 18% during 2020 – 2027
- Harmony, Verifi, and Panorama are the Most Popular NIPT Test Available in the United States
“U.S. Non-Invasive Prenatal Testing Market – Growth, Demand, Trends, Opportunity, Forecasts (2020 – 2027)” is based on an inclusive study of the entire United States non-invasive prenatal testing market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States non-invasive prenatal testing market. The study also presents a comprehensive analysis of the market dynamics and estimation of the market size over the forecast period 2020 – 2027. The report delivers a clear understanding of the up-to-date and future growths of the United States’ non-invasive prenatal testing market.
The Key Market Players for the United States Non–Invasive Prenatal Testing Market Are Listed Below:
- Illumina
- Natera
- Quest Diagnostics
- Myriad Genetics
- Centogene
- GenPath
- Progenity
- PerkinElmer
- Yourgene Health
- Invitae Corporation
- Agilent Technologies
- Ariosa Diagnostics (Roche)
- Integrated Genetics (LabCorp)
For More Information@ https://dpiresearch.com/u-s-non-invasive-prenatal-testing-market-growth/
Contact Us:
Maria Rai
Head of Business Development
DPI Research
Direct Line: +91-766-764-8693
E-mail: [email protected]
